Key result
Machine learning models predict hyponatremia risk in older adults with an AUROC of ~0.75.
Why the study?
Early identification of hyponatremia in older adults is hindered by complex, non-linear interactions between comorbidities and polypharmacy.
Cohort (n=653,396)
Yes
Machine learning models using claims data can effectively rule out low-risk older adults for hyponatremia, though performance gaps remain in highly vulnerable subgroups.
Answers are grounded in this paper and cite their sources.
Moderate discrimination may aid hyponatremia risk stratification in older adults; leaves open prospective validation before clinical adoption.
Background/Objectives: Hyponatremia is a clinically important electrolyte disorder in older adults, yet early identification is hindered by complex, non-linear interactions between comorbidities and polypharmacy. This study aimed to develop and externally validate a machine learning (ML) prediction model for hyponatremia risk using nationwide claims data, focusing on medication patterns and clinical features. Methods: A retrospective cohort study was conducted using the South Korean Health Insurance Review and Assessment Service-Aged Patient Sample (HIRA-APS). Data from 2017 to 2018 were used for development, and 2019 data for temporal external validation (age ≥ 65). SHapley Additive exPlanations (SHAP)-based recursive feature elimination identified 33 high-impact predictors from 60 clinical features. Six ML algorithms, including LightGBM and CatBoost, were trained with 1:4 case–control matching and evaluated for discrimination and calibration. Results: The development and validation cohorts included 4810 and 648,586 patients, respectively. All models showed comparable discriminative performance (area under the receiver operating characteristic curve [AUROC] 0.741–0.746), with LightGBM achieving the highest (AUROC 0.746; 95% confidence interval (CI) 0.728–0.763). The models had very high negative predictive values (>0.999) for ruling out low-risk individuals. Tree-based ensemble matched linear models in discrimination but achieved better calibration. Conclusions: These validated, interpretable ML models can serve as clinical decision support tools that rule out low-risk patients and prioritize monitoring for high-risk individuals. Across sociodemographic subgroups, calibration was maintained after recalibration, whereas discrimination was lower in the oldest, most comorbid, frailest, highest-medication-burden, and lowest-socioeconomic groups—a gap to address before equitable deployment.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) conducted a cohort in Hyponatremia (n=653,396). Machine learning prediction models was evaluated on Discriminative performance for hyponatremia risk (AUROC) (AUROC 0.746, 95% CI 0.728-0.763). Machine learning models, specifically LightGBM, successfully predicted hyponatremia risk in older adults with an AUROC of 0.746 (95% CI 0.728-0.763) and a negative predictive value >0.999.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: